Evaluating Digital Therapeutics, Drugs, and Health Technology for Optimizing Clinical and Financial Outcomes Home Study

ACPE UAN #:  0233-0000-20-033-H04-P

Release Date:  April 22, 2020

Expiration Date: April 22, 2023

Activity Type: Knowledge-based

Contact Hours: 1.0 contact hours

Activity Fee:  Member:  Free              Non-Member:  $30

Target Audience:  Pharmacists who practice in managed care settings.

Activity Description:

Utilization management practices are applied to medications in many therapeutic areas, but present unique challenges with digital therapeutics (DTx) and digital health tools. These practices play an important role in optimizing and driving utilization patterns towards clinically- and cost-effective products, but the application of inappropriate exclusions can negatively affect the overall health care spend. Digital therapeutics is a nascent field, and many questions exist on what part they play in overall treatment. Furthermore, the regulatory approval process for DTx is not well understood by plan sponsors, which may result in failing to optimize clinical and financial outcomes by plans.

This session will provide clarification on how rebates, comparative effectiveness research, and new-to-market block plan designs influence decision makers determining which medications, DTx, and health technology tools are ultimately excluded from formularies.

Learning Objectives: 

At the completion of this activity, participants should be able to:

  1. Evaluate how exclusionary practices play an important role in driving utilization patterns towards clinically and cost-effective medications, digital therapeutics, and health technology.
  2. Analyze opportunities and challenges plan sponsors and payers face in determining how digital therapeutics and health technology tools are incorporated or excluded from formularies.
  3. Apply best practices, including comparative effectiveness research and pharmacoeconomic and rebate analyses, to ensure clinical and financial outcomes for all relevant stakeholders.

Schedule of Educational Activity

This activity consists of an audio recording, pre-test assessment questions (not required to pass to continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation.

CPE Requirements:

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live webinar activity presented at AMCP eLearning Days.

CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements:  System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.  View the minimum technical and system requirements for continuing education online learning activities.

As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities.  It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

Statement of Commercial Support: This educational activity is supported in part by an unrestricted educational grant from Novo Nordisk, Inc.

Moderator:

Betty Whitaker, Vice President, Membership & Meetings, AMCP, Alexandria, Virginia

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-20-033-H04-P 1 Contact Hour April 22, 2020 - April 22, 2023